Goodbody Health Inc
Change company Symbol lookup
Select an option...
GDBYF Goodbody Health Inc
ZH Zhihu Inc
BWXT BWX Technologies Inc
HYZNW Hyzon Motors Equity Warrants Exp 2nd Oct 2025 *W EXP 10/02/2025
HBNC Horizon Bancorp Inc
WYNMY Wynn Macau Ltd
BOAS BOA Acquisition Corp
NKTR Nektar Therapeutics
BB BlackBerry Ltd
DXCM Dexcom Inc
Go


Based in Canada
Company profile

Goodbody Health Inc., formerly Sativa Wellness Group Inc., is a Canada-based wellness company. The Company operates both in wellness testing in the United Kingdom and as a vertically integrated cannabinoid (CBD) company that operates in the United Kingdom and the European Union. It operates under one segment: the sale of cannabinoid products and clinic and cannabinoid testing. The Company focuses on offering COVID and blood testing clinics, CBD extraction, wholesale bulk isolate and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs. It provides a local level network of approximately 140 clinics, providing over 30 blood and polymerase chain reaction (PCR) tests for at home or in clinic testing. The Company’s subsidiaries include Borganic, Olimax, Olimax RE, Sativa Wellness Group Poland, Sativa Group, Goodbody Botanicals and Phytovista Laboratories.

The symbol you entered, SCNNF, changed to GDBYF.

Price
Delayed
$0.0159
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)

Today's volume of 0 shares is on pace to be much lighter than GDBYF's 10-day average volume of 164,805 shares.

0

Display:

Providers:

UpdateCancel
6 providers
August 10, 2022
Goodbody Health Inc. Provides Annual General and Special Meeting of Shareholders Update

VANCOUVER, BC / ACCESSWIRE / August 10, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody" or the "Company"), is pleased to announce the results of the Company's Annual General and Special Meeting of the shareholders held on August...(Accesswire)

July 14, 2022
Goodbody Health Announces Annual General and Special Meeting of Shareholders

VANCOUVER, BC / ACCESSWIRE / July 14, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), announces that further to its news release dated June 10, 2022, the Company has mailed its proxy materials, with instructions...(Accesswire)

June 20, 2022
Goodbody Health launches Genetic Risk Testing for Cancer and Cardiovascular Diseases

VANCOUVER, BC / ACCESSWIRE / June 20, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that it is launching new genetic cancer tests to help customers gauge and understand their cancer...(Accesswire)

June 16, 2022
Goodbody Health Granted Care Quality Commission Registration

VANCOUVER, BC / ACCESSWIRE / June 16, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that following its application for registration with the Care Quality Commission (CQC) last year...(Accesswire)

June 10, 2022
AGM, Plan to De-List from the CSE, Redomicile to Guernsey, And Appointment of Peterhouse as Corporate Adviser

Aligns With Company's Substantial U.K. Presence and Supports Its Growth Strategy Redomicile to Guernsey VANCOUVER, BC / ACCESSWIRE / June 10, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody" or the "Company"), today announced...(Accesswire)

May 26, 2022
Goodbody Health Announces the Launch of Its Core Health Diagnostic Check

VANCOUVER, BC / ACCESSWIRE / May 26, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce that, it has launched its core UK Health check which offers a comprehensive summary of a person's...(Accesswire)

May 25, 2022
Goodbody Health Inc. Publishes Highest Quarterly Profit to Date in Q1 2022

VANCOUVER, BC / ACCESSWIRE / May 25, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased to announce its highest comprehensive profit of £0.10m and adjusted EBITDA of £0.23m in its unaudited Interim...(Accesswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.